Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: A meta-analysis of cardiovascular outcomes trials

Publisher Website
Google Scholar
Abstract
No abstract available
Funding Information
  • National Key Research and Development Program of China (2017YFC1309800, 2017YFC0909600)
  • The Clinical Research Fund of Chinese Medical Association (15010010589)
  • the Research Fund for Public Welfare, National Health and Family Planning (201402005)
  • Key Research and Department of Shandong Province (2016GSF201013)